Sign in

Research summary ·

Human papillomavirus (HPV) vaccination for the prevention of cervical cancer and other HPV-related diseases: a network meta-analysis.

Written based on 1 research study on PubMed, searched on 3 Nov 2026.

What was studied

This was a network meta-analysis of randomised trials of HPV vaccines. It checked safety and efficacy against cervical cancer and other HPV-related diseases. HPV means human papillomavirus. It covered females and males. The team used trial reports from the European Medicines Agency. It included 60 studies with 157,414 participants. Follow-up went up to 11 years.

What they found

The studies were not long enough for cancers to develop. No cancers were detected in the studies that reported on cancer. In females aged 15 to 25, vaccination lowered CIN2+. The drop was larger for HPV types that the vaccine targets. In females over 25, there was little to no difference with Cervarix or Gardasil. Serious adverse events differed little between vaccine and control groups. Certainty was high. Fewer people needed treatment for pre-invasive disease. Anogenital warts were also reduced, with high certainty. For females aged 15 to 25, Gardasil-9 was most likely to reduce warts.

What it means for patients

The team says trials show HPV vaccination lowers pre-cancer outcomes. These include CIN2+ and anogenital warts. They found no data on cervical cancer or other cancers. They say no safety concerns were noted in the studies.

Why it is not certain yet

There were no data on cancer outcomes. Pre-cancer data did not cover people under age 15. No studies covered males under 15 or over 25. Certainty was low for some outcomes, such as anal and penile changes. A review is only as good as its trials.

The registered trials

The paper names these trials from a public trial registry. Each trial page shows who the trial is for, its sites and its status.

Source

Human papillomavirus (HPV) vaccination for the prevention of cervical cancer and other HPV-related diseases: a network meta-analysis.

PubMed · PMID 41276263

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Cervical cancer publications